Collectively, our data support a model of medulloblastoma development inSB-mutagenised Ptch+/- mice which involves disruption of a novel transcriptionfactor network leading to Igf2 upregulation, proliferation of GNPs,and tumour formation. The gene discussed is IGF2; the disease is medulloblastoma.